MIIM
SUPN icon

Mesirow Institutional Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Mesirow Institutional Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,165
Closed -$245K – 127
2023
Q2 		$245K Sell
8,165
-179,135
-96% -$6.27M 0.03% 113
2023
Q1 		$6.79M Sell
187,300
-87,955
-32% -$3.38M 0.74% 70
2022
Q4 		$9.82M Sell
275,255
-49,830
-15% -$1.73M 1.29% 23
2022
Q3 		$11M Buy
+325,085
New +$10.6M 1.6% 12

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mesirow Institutional Investment Management's SUPN Position: Q3 2023 in Review

Mesirow Institutional Investment Management sold out of Supernus Pharmaceuticals (SUPN) in Q3 2023, closing a stake of 8,165 shares — an estimated $245K sold.

Mesirow Institutional Investment Management first reported a position in SUPN in Q3 2022 and held it in 4 quarters. The position peaked at $11M in Q3 2022. 238 funds tracked by Wall St. Rank hold SUPN as of Q3 2023.

  • Mesirow Institutional Investment Management reported no remaining Supernus Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Mesirow Institutional Investment Management sold 8,165 Supernus Pharmaceuticals shares in Q3 2023, an estimated $245K.
  • Mesirow Institutional Investment Management first reported a position in Supernus Pharmaceuticals in Q3 2022 and held it in 4 quarters.
  • Mesirow Institutional Investment Management's Supernus Pharmaceuticals position peaked at $11M in Q3 2022.
  • 238 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2023.

Based on Mesirow Institutional Investment Management's 13F filing for Q3 2023, filed 1 Nov 2023.